Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Merson

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
Trials|November 14, 2014
CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trialJeremy Day, Darma Imran, Ahmed Rizal Ganiem, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
The Lancet. Respiratory Medicine|January 14, 2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort studyRishi K Gupta, Ewen M Harrison, Antonia Ho, et al.
Elife|October 5, 2022
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsBronner P Gonçalves, Matthew Hall, Waasila Jassat, et al.
ERJ Open Research|February 16, 2022
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational studyLuis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
BMJ Public Health|January 21, 2026
Dengue therapeutics consortium 2025: a global collaboration in actionAngela McBride, Ho Quang Chanh, Huynh Trung Trieu, et al.
International Journal of Epidemiology|February 28, 2023
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, et al.
The Lancet. Infectious Diseases|October 10, 2025
Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)Sophie Yacoub, Anastasia Demidova, Xin Hui S Chan, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
BMJ (Clinical Research Ed.)|September 10, 2020
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality ScoreStephen R Knight, Antonia Ho, Riinu Pius, et al.
Thorax|November 23, 2021
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation ProtocolStephen R Knight, Rishi K Gupta, Antonia Ho, et al.
Trials|November 14, 2014
CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trialJeremy Day, Darma Imran, Ahmed Rizal Ganiem, et al.
Lancet (London, England)|July 18, 2021
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort studyThomas M Drake, Aya M Riad, Cameron J Fairfield, et al.
The Lancet. Respiratory Medicine|January 14, 2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort studyRishi K Gupta, Ewen M Harrison, Antonia Ho, et al.
Elife|October 5, 2022
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsBronner P Gonçalves, Matthew Hall, Waasila Jassat, et al.
ERJ Open Research|February 16, 2022
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational studyLuis Felipe Reyes, Srinivas Murthy, Esteban Garcia-Gallo, et al.
BMJ Public Health|January 21, 2026
Dengue therapeutics consortium 2025: a global collaboration in actionAngela McBride, Ho Quang Chanh, Huynh Trung Trieu, et al.
International Journal of Epidemiology|February 28, 2023
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, et al.
The Lancet. Infectious Diseases|October 10, 2025
Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE)Sophie Yacoub, Anastasia Demidova, Xin Hui S Chan, et al.
Pageof 11